Diagnostics (Mar 2023)

Ophthalmic Vein Thrombosis Associated with Factor V Leiden and MTHFR Mutations

  • Cosmin Adrian Teodoru,
  • Mihnea Munteanu,
  • Nadina Mercea,
  • Alina Moatar,
  • Horia Stanca,
  • Florina Georgeta Popescu,
  • Horațiu Dura,
  • Adrian Hașegan,
  • Doina Ileana Giurgiu,
  • Maria-Emilia Cerghedean-Florea

DOI
https://doi.org/10.3390/diagnostics13061052
Journal volume & issue
Vol. 13, no. 6
p. 1052

Abstract

Read online

Superior ophthalmic vein thrombosis (SOVT) is a rare clinical entity that may be associated with hypercoagulability status. We present a case of a 77-year-old woman who presented to the emergency department complaining of eye ptosis, chemosis and conjunctival congestion in the right eye (RE). The ophthalmological examination revealed best-corrected visual acuity (BCVA) was 0.5 for the right eye (RE) 0.5 and 0.06 for the left eye (LE). Intraocular pressure (IOP) was 25 mmHg in RE and 14 mmHg in LE. Non-contrast computed tomography (CT) of the brain and orbits revealed a hyperreflectivity at the level of the right ophthalmic vein and inferior rectus muscle hypertrophy. An extensive hypercoagulable panel was completed and we found a positive result for Factor V Leiden (heterozygous mutation) and methyl-enetetrahydrofolate reductase (MTHFR-C677T homozygous mutations). Systemic steroidal anti-inflammatory and anticoagulant treatments were started immediately. Gradual resolution of symptoms was noted during the hospitalization, and BCVA in her RE was established at 0.7 at the 10-week follow-up.

Keywords